Throat Cancer Treatment Market Overview
Throat Cancer Treatment Market size is forecast to reach 3.89Bn by 2025, growing at a CAGR of 7.87% during the forecast period 2020-2025. Throat cancer refers to cancerous tumors that develop in throat (pharynx), voice box (larynx) or tonsils. Increasing incidence of throat cancer and increasing awareness regarding the throat cancer are the major factors driving the growth of the market. Increasing smoking population is set to further enhance the overall market demand of throat cancer treatment during the forecast period 2020-2025.
The report: “Throat Cancer Treatment Market Forecast (2019-2025)”, by IndustryARC, covers an in-depth analysis of the following segments of the Throat Cancer Treatment Market.
By Type: Pharyngeal Cancer and Laryngeal Cancer
By Treatment Type: Radiation Therapy, Surgery, Chemotherapy, Targeted Drug Therapy, Rehabilitation and Palliative Treatment
By End Users: Hospitals, Ambulatory Surgical Centers, Clinics and Others
By Geography: North America, Europe, Asia Pacific and RoW
- North America dominates the Throat Cancer Treatment Market owing to the increasing smoke pollution and increasing alcohol consumption. The Throat Cancer Treatment Market scope for different regions will be provided in the final report.
- The increasing incidence rate of pharyngeal cancer and rising aging population is likely to aid in the market growth of throat cancer treatment.
- Detailed analysis on the Strength, Weakness and Opportunities of the prominent players operating in the market will be provided in the Throat Cancer Treatment Market report.
- Side effects of chemotherapy drugs and lack of proper diagnosis of the disease is set to create hurdles for the Throat Cancer Treatment Market
Type - Segment Analysis
The Laryngeal Cancer segment held the largest share in the Throat Cancer Treatment Market
in 2019 and is estimated to grow at a CAGR of 6.34% during the forecast period 2020-2025. Laryngeal cancers are mostly squamous cell carcinomas, reflecting their origin from the skin of the larynx. Cancer can develop in any part of the larynx, but the cure rate is affected by the location of the tumor. For the purposes of staging, the larynx is divided into three anatomical regions- the glottis (true vocal cords, anterior and posterior commissures), the supraglottis (epiglottis, arytenoids and aryepiglottic folds, and false cords) and the subglottis. Laryngeal cancer is set to spread by direct extension to adjacent structures, by metastasis to regional cervical lymph nodes or more distantly, through the blood stream. The most important risk factor for laryngeal cancer is smoking. Laryngeal Cancer is set to be the fastest growing segment during the forecast period 2020-2025.
Treatment Type- Segment Analysis
Chemotherapy segment held the largest share in the Throat Cancer Treatment Market in 2019 and is estimated to grow at a CAGR of 5.19% during the forecast period 2020-2025. Chemotherapy uses drugs to kill cancer cells. Chemotherapy is often used along with radiation therapy in treating throat cancers. Certain chemotherapy drugs make cancer cells more sensitive to radiation therapy. But combining chemotherapy and radiation therapy increases the side effects of both treatments. Radiation therapy uses high energy beams from sources such as X-rays and protons to deliver radiation to the cancer cells, causing them to die. Radiation therapy can come from a large machine outside your body (external beam radiation) or radiation therapy can come from small radioactive seeds and wires that can be placed inside your body, near your cancer (brachytherapy). Chemotherapy is set to be the fastest growing segment during the forecast period 2020-2025 boosting the growth of the Throat Cancer Treatment Market.
Geography - Segment Analysis
North America dominates the throat cancer treatment market with a share of more than 39%, followed by Europe owing to the increasing smoke pollution and increasing alcohol consumption. Rising aging population and increasing prevalence of both pharyngeal cancer and laryngeal cancer is boosting the growth of the throat cancer treatment market.
However, Europe is estimated to grow at a higher CAGR during the forecast period 2020-2025 owing to the increase in tobacco and alcohol consumption in this region.
Throat Cancer Treatment Market Drivers
Increasing incidence of throat cancer and increasing awareness regarding the throat cancer
Increasing incidence of throat cancer and increasing awareness regarding the throat cancer is increasing the growth of the throat cancer treatment market. Throat cancer refers to cancerous tumors that develop in your throat, voice box or tonsils. Throat cancer can also affect the piece of cartilage that act as a lid for your wide pipe. Tonsil cancer, another form of throat cancer, affects the tonsils, which are located on the back of the throat. Throat cancer occurs when cells in your throat develop genetic mutations. These mutations cause cells to grow uncontrollably and continue living after healthy cells would normally die. The accumulating cells can form a tumor in your throat. It’s not clear what causes the mutation that causes throat cancer. The symptoms of throat cancer are cough, change in voice, sore throat, ear pain and difficulty in swallowing and many more. Increasing awareness regarding the throat cancer is boosting the growth of the throat cancer treatment market.
Increasing smoking population
Increasing smoking population is increasing the growth of the throat cancer treatment market. Smoking is a practice in which a substance is burned and the resulting smoke breathed in to be tasted and absorbed into the bloodstream. the substance used is the dried leaves of the tobacco plant, which have been rolled into a small square of rice paper to create a small, round cylinder called a "cigarette". Smoking is primarily practiced as a route of administration for recreational drug use owing the combustion of the dried plant leaves vaporizes and delivers active substances into the lungs where they are rapidly absorbed into the bloodstream and reach bodily tissue. Smoking is one of the most common forms of recreational drug use which leads to throat cancer. Thus, boosting the growth of the throat cancer treatment market.
Throat Cancer Treatment Market Challenges
Side effects of chemotherapy drugs and lack of proper diagnosis of the disease
Some of the factors that is set to impede the growth of the Throat Cancer Treatment Market are side effects of chemotherapy drugs and lack of proper diagnosis of the disease.
Throat Cancer Treatment Industry Outlook
Product launches, mergers and acquisitions, joint ventures and R&D activities are key strategies adopted by players in the throat cancer treatment market. In 2019, Throat Cancer Treatment Market share is consolidated by the top ten players present in the market. Throat Cancer Treatment, top 10 companies are Bristol Myers Squibb Co, Hospira Inc, Baxter International Inc, Teva Pharmaceutical Industries Ltd, Mylan Pharmaceuticals Inc, App Pharmaceuticals LLC., Sanofi-Aventis and Intas Pharmaceuticals Ltd among others.
- In November 2019, Bristol Myers Squibb Co acquires Celgene.
- In October 2016, Sanofi Aventis acquires INTA Pharmaceuticals.
- In July 2019, Baxter International Inc acquires Claris Injectables.
1. Throat Cancer Treatment Market - Overview
1.1 Definitions and Scope
2. Throat Cancer Treatment Market - Executive Summary
2.1 Market Revenue and Key Trends by Company
2.2 Key trends by Type
2.3 Key trends by Geography
3. Throat Cancer Treatment Market – Comparative Analysis
3.1 Product Benchmarking – Key Companies
3.2 Financial Analysis – Key Companies
3.3 Market Value Split by Key Companies
3.4 Patent Analysis – Key Companies
3.5 Pricing Analysis
4. Throat Cancer Treatment Market - Startup Companies Scenario (Premium)
4.1 Key Startup Company Analysis by
4.1.3 Venture Capital and Funding Scenario
5. Throat Cancer Treatment Market – Industry Market Entry Scenario Premium (Premium)
5.1 Regulatory Framework Overview
5.2 New Business and Ease of Doing business index
5.3 Case Studies of Successful Ventures
6. Throat Cancer Treatment Market Forces
6.1 Market Drivers
6.2 Market Constraints/Challenges
6.3 Porters five force model
6.3.1 Bargaining power of suppliers
6.3.2 Bargaining powers of customers
6.3.3 Threat of new entrants
6.3.4 Rivalry among existing players
6.3.5 Threat of substitutes
7. Throat Cancer Treatment Market – Strategic Analysis
7.1 Value Chain Analysis
7.2 Opportunities Analysis
7.3 Market Life Cycle
8. Throat Cancer Treatment Market – By Type (Market Size –$Million/$Billion)
8.1 Pharyngeal Cancer
8.2 Laryngeal Cancer
9. Throat Cancer Treatment Market – By Treatment Type (Market Size –$Million/$Billion)
9.1 Radiation Therapy
9.4 Targeted Drug Therapy
9.5 Rehabilitation After Treatment
9.6 Palliative Care
10. Throat Cancer Treatment Market – By End Users (Market Size –$Million/$Billion)
10.2 Ambulatory Surgical Centers
11. Throat Cancer Treatment Market - By Geography
11.1 North America
11.2.6 Rest of Europe
11.3 Asia Pacific
11.3.4 South Korea
11.3.6 New Zealand
11.3.7 Rest of APAC
11.4 Rest of the World
11.4.1 Middle East
11.4.3 South America
12. Throat Cancer Treatment Market - Entropy
13. Throat Cancer Treatment Market – Industry/Segment Competition Landscape (Premium)
13.1 Market Share Analysis
13.1.1 Global Market Share – Key Companies
13.1.2 Market Share by Region – Key companies
13.1.3 Market Share by Countries – Key Companies
13.1.4 Best Practices for Companies
14. Throat Cancer Treatment Market – Key Company List by Country Premium (Premium)
15. Throat Cancer Treatment Market Company Analysis
15.1 Company 1
15.2 Company 2
15.3 Company 3
15.4 Company 4
15.5 Company 5
15.6 Company 6
15.7 Company 7
15.8 Company 8
15.9 Company 9
15.10 Company 10 and more
"*Financials for private companies would be provided on a best efforts basis”.